The European Union health regulator on Friday recommended expanded use of GSK's respiratory syncytial virus (RSV) vaccine in adults aged between 50 and 59.
July 26, 2024
U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns
September 22, 2023
Fall vaccination season is in full swing, with health officials urging both an updated COVID-19 shot and flu vaccine for most everyone
September 28, 2023
A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
October 24, 2023
Newly approved and updated vaccines are the best tools available to combat COVID-19, the flu and RSV, as infections and hospitalizations tick upward and cold and flu season gets underway.
October 12, 2023
RSV infections are rising sharply in some parts of the country, nearly filling hospital emergency departments in Georgia, Texas and some other states
November 16, 2023
U.S. health officials say flu is picking up steam while RSV lung infections may be peaking
December 01, 2023
Moderna on Thursday reported a surprise fourth-quarter profit helped by cost cutting and some deferred payments, and the vaccine maker set out a
April 26, 2024
Health officials are investigating whether there's a link between two new RSV vaccines and cases of a rare nervous system disorder
February 29, 2024
Reports of a rare nervous system disorder are “more common than expected” in older U.S. adults who got the new RSV vaccines
May 30, 2024
Federal health officials are strengthening their endorsement of RSV vaccinations for people 75 and older
June 26, 2024
GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its age recommendation for use of respiratory syncytial virus
June 27, 2024
Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the
June 27, 2024
Moderna Inc respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months, the drugmaker said on Wednesday.
June 26, 2024
Merck's antibody-based shot met the main goal of a mid-to-late stage trial, when tested to protect infants against a disease caused by the respiratory syncytial virus (
July 23, 2024
Boeing factory workers are voting whether to strike and shut down aircraft production
Durex makes India condom push for women, rural consumers
Australia introduces bill to step up fight against hate crimes
Hundreds gather on Seattle beach to remember American activist killed by Israeli military
Russian hawk pushes case for Putin to toughen policy on nuclear weapons
Billionaire's spacewalk with SpaceX delayed several hours hundreds of miles above Earth
Thai consumer confidence drops to 13-month low in August as growth slows
Murdoch succession battle to play out in Nevada courtroom
Pac-12 targeting Boise St., Fresno St., San Diego St., Colorado St. for rebuild, AP sources say
Reggie Bush was at his LA-area home when 3 male suspects attempted to break in